Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence Based Predictive Scoring System to Identify the Risk of Developing Cardiogenic Shock (CS) in Patients Suffering From Acute Coronary Syndrome (ACS)

NCT05570864 is registered in ClinicalTrials.gov with Premedix Academy as lead sponsor.

NCT NCT05570864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05570864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence Based Predictive Scoring System to Identify the Risk of Developing Cardiogenic Shock (CS) in Patients Suffering From Acute Coronary Syndrome (ACS)
Lead sponsor
Premedix Academy
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2022
Completion date
December 31, 2023
Enrollment
50,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, acute myocardial infarction, cardiogenic shock